Comparative study of effect of Withania somnifera as an adjuvant to DOTS in patients of newly diagnosed sputum smear positive pulmonary tuberculosis

World Health Organization, 2014 2015 Cooper, 2008, The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis, Immunol Rev, 226, 191, 10.1111/j.1600-065X.2008.00702.x Flynn, 2001, Immunology of tuberculosis, Annu Rev Immunol, 19, 93, 10.1146/annurev.immunol.19.1.93 MacMicking, 1999, Nitric oxide and macrophage function, Annu Rev Immunol, 15, 323, 10.1146/annurev.immunol.15.1.323 Chan, 2004, The immunological aspects of latency in tuberculosis, Clin Immunol, 110, 2, 10.1016/S1521-6616(03)00210-9 Tufariello, 2003, Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection, Lancet Infect Dis, 3, 578, 10.1016/S1473-3099(03)00741-2 Cho, 2000, Antimicrobial activity of MHC class I-restricted CD81 T cells in human tuberculosis, PNAS, 97, 12210, 10.1073/pnas.210391497 Stenger, 1998, An antimicrobial activity of cytolytic T cells mediated by granulysin, Science, 282, 121, 10.1126/science.282.5386.121 Caruso, 1999, Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis, J Immunol, 162, 5407, 10.4049/jimmunol.162.9.5407 Tascon, 1998, Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon, Infect Immunity, 66, 830, 10.1128/IAI.66.2.830-834.1998 Kirtikar, 1991, 1783 Kostromina, 2003, Evaluation of the efficacy of plant adaptogen (Spirulina) in the pathogenic therapy of primary tuberculosis in children, LiK Sprava, 5, 102 Sarawathy, 2001, Effect of Liv 100 on antioxidant status in patients administered with different anti-TB drug regimens, Biomedicine, 21, 56 Jain, 2010 Ved, 2008 World Health Organization, 2009, Radix Withaniae, vol. 4, 373 United States Pharmacopeia Convention, 2013, Ashwagandha root; powdered Ashwagandha root; and powdered Ashwagandha root extract, 1336 Chopra, 1958, 134 Indian Pharmacopoeia Ashwagandha, 1985 Indian Pharmacopoeia Commission, 2015 Singh, 1998 Singh, 1982, Withania somnifera (Ashwagandha), a rejuvenating herbal drug which enhances survival during stress (an adaptogen), Int J Crude Drug Res, 20, 29, 10.3109/13880208209083282 Ziauddin, 1996, Studies on the immunomodulatory effects of Ashwagandha, J Ethnopharmacol, 50, 69, 10.1016/0378-8741(95)01318-0 Dhuley, 1997, Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice, J Ethnopharmacol, 58, 15, 10.1016/S0378-8741(97)00072-X Agarwal, 1999, Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation, J Ethanopharmocol, 67, 27, 10.1016/S0378-8741(99)00065-3 Sumantran, 2008, The relationship between chondroprotective and anti-inflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitro, Phytother Res, 22, 1342, 10.1002/ptr.2498 Mirjalili, 2009, Steroidal lactones from Withania somnifera, an ancient plant for novel medicine, Molecules, 14, 2373, 10.3390/molecules14072373 Kaur, 2004, Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha, Food Chem Toxicol, 42, 2015, 10.1016/j.fct.2004.07.015 Ghosal, 1989, Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera, Phytother Res, 3, 201, 10.1002/ptr.2650030510 Mikolai, 2009, In vivo effects of Ashwagandha (Withania somnifera) extract on the activation of lymphocytes, J Altern Complement Med, 15, 423, 10.1089/acm.2008.0215 Chaterjee, 2000, Role of Ashwagandha in the treatment of difficult tuberculosis, Indian J Tuberc, 47, 171 Pandey, 1996, Ashwagandha as immunoadjuvant with chemotherapy in management of pulmonary tuberculosis, Natl Conf Tuberc Chest Dis, 17, 154 Dhingra, 2003, Health related quality of life (HRQL) scoring in tuberculosis, Indian J Tuberc, 50, 99 Kimmatkar, 2003, Phytomedicine, 10, 3, 10.1078/094471103321648593